Cargando…

Brief assessment of priority symptoms in hormone refractory prostate cancer: The FACT Advanced Prostate Symptom Index (FAPSI)

BACKGROUND: The objective of this study was to construct and validate a brief, clinically-relevant symptom index for advanced prostate cancer. METHODS: Questions were extracted from a commonly-used multi-dimensional cancer quality of life instrument with prostate-specific items, the Functional Asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yount, Susan, Cella, David, Banik, Donald, Ashraf, Talat, Shevrin, Daniel
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305353/ https://www.ncbi.nlm.nih.gov/pubmed/14633279 http://dx.doi.org/10.1186/1477-7525-1-69

Ejemplares similares

Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index‐10 (FHNSI‐10)
por: Shaunfield, Sara, et al.
Publicado: (2021)

A brief symptom index for advanced renal cell carcinoma
por: Eton, David T, et al.
Publicado: (2006)

Pathogenesis of prostate cancer and hormone refractory prostate cancer
por: Girling, J. S., et al.
Publicado: (2007)

Leptomeningeal Metastases in Hormone Refractory Prostate Cancer
por: Ng, Jessica Y, et al.
Publicado: (2018)

Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials
por: Shaunfield, Sara, et al.
Publicado: (2019)

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
por: Armstrong, Andrew J, et al.
Publicado: (2007)

Update in palliative management of hormone refractory cancer of prostate
por: Singh, Pratipal, et al.
Publicado: (2007)

A brief assessment of physical functioning for prostate cancer patients
por: Lai, Jin-Shei, et al.
Publicado: (2010)

Hormonal manipulation of lower urinary tract symptoms secondary to benign prostatic obstruction
por: Raja, Adita, et al.
Publicado: (2014)

Correlation Between the Visual Prostate Symptom Score and International Prostate Symptom Score in Patients With Lower Urinary Tract Symptoms
por: Park, Yeon Won, et al.
Publicado: (2014)

Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy‐Lung (FACT‐L) and the FACT‐Lung Symptom Index (FLSI)
por: Juliana, Franceschini, et al.
Publicado: (2010)

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
por: Sinibaldi, Victoria J
Publicado: (2007)

Hormone refractory prostate cancer: Current understanding and future perspectives
por: Khochikar, Makarand
Publicado: (2007)

Rescoring the NIH Chronic Prostatitis Symptom Index (NIH-CPSI): Nothing New
por: Clemens, J. Quentin, et al.
Publicado: (2009)

Effect of obesity on International Prostate Symptom Score and prostate volume
por: Yelsel, Kazım, et al.
Publicado: (2015)

International Prostate Symptom Score and Quality of Life Index for Lower Urinary Tract Symptoms Are Associated with Aging Males Symptoms Rating Scale for Late-Onset Hypogonadism Symptoms
por: Tsuru, Takamitsu, et al.
Publicado: (2023)

TITAN trial; shifting focus from hormone-refractory to hormone-sensitive prostate cancer
por: Kumar, Gautam
Publicado: (2020)

Genomic predictors for treatment of late stage prostate cancer
por: Shevrin, Daniel H
Publicado: (2016)

Bacteria and the prostate: infertility versus symptoms
por: Pontari, Michel A
Publicado: (2014)

Can new, improvised Visual Prostate Symptom Score replace the International Prostate Symptom Score? Indian perspective
por: Sanman, K. N, et al.
Publicado: (2020)

Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
por: Lam, Marnix G. E. H., et al.
Publicado: (2008)

Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
por: Tsakalozou, Eleftheria, et al.
Publicado: (2012)

Phosphorylation of the Androgen Receptor by PIM1 in Hormone Refractory Prostate Cancer
por: Ha, Susan, et al.
Publicado: (2012)

The Relationships between Thyroid Hormone Levels and Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia
por: Lee, Jun Ho, et al.
Publicado: (2019)

Symptom burden among patients with Renal Cell Carcinoma (RCC): content for a symptom index
por: Harding, Gale, et al.
Publicado: (2007)

Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
por: Kim, Jong Min, et al.
Publicado: (2011)

Comparison of Visual Prostate Symptom Score and International Prostate Symptom Score in the evaluation of men with benign prostatic hyperplasia: A prospective study from an Indian population
por: Taneja, Yogesh, et al.
Publicado: (2017)

Outcomes of Prostate Artery Embolisation in Patients with Severe Symptoms of Benign Prostate Hyperplasia
por: ABDUL RAHIM, Rohana, et al.
Publicado: (2021)

Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire
por: Gewanter, Richard M., et al.
Publicado: (2023)

Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients
por: Li, Bing-Hui, et al.
Publicado: (2019)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

Reliability and validity of the National Institutes of Health Chronic Prostatitis Symptom Index questionnaire in the Turkish Population
por: COŞKUN, Alper, et al.
Publicado: (2021)

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
por: Edwards, J, et al.
Publicado: (2003)

Terminal dribbling in male patients with lower urinary tract symptoms: relationship with International Prostate Symptom Score and with intravesical prostatic protrusion
por: Kim, Jae Heon, et al.
Publicado: (2015)

Validation of the Arabic linguistic version of the Danish Prostatic Symptom Score for benign prostatic hyperplasia associated with lower urinary tract symptoms
por: Hashem, Abdelwahab, et al.
Publicado: (2021)

Abiraterone acetate, an inhibitor of adrenal androgen synthesis in “hormone refractory prostate cancer”
por: Goel, Arun Kumar, et al.
Publicado: (2011)

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer
por: Calcagno, Fabien, et al.
Publicado: (2012)

EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment
por: Guérin, Olivier, et al.
Publicado: (2010)

Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
por: Hu, Meichun, et al.
Publicado: (2015)

Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer
por: Tam, L, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1ugiqldihvvcbpvvr24tqa54bd